Back to Results
First PageMeta Content



PIPELINE WATCH CoAprovel SPCs still prove contentious xpiries in mid-October of supplementary protection certificates (SPCs) for Sanofi’s CoAprovel (irbesartan/hydrochlorothiazide) across western Europe come against a
Add to Reading List

Document Date: 2014-05-07 19:25:21


Open Document

File Size: 47,42 KB

Share Result on Facebook